Evidence map›Paper›PMID 38112424›Full record

ArticleApplied and environmental microbiology2024

An atypical two-component system, AtcR/AtcK, simultaneously regulates the biosynthesis of multiple secondary metabolites in

Yu-Si Yan, Li-Sha Zou, He-Geng Wei, Meng-Yao Yang, Yun-Qi Yang, Xiao-Fang Li, Hai-Yang Xia

Open access · greenAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. LuxR-Type Regulator RRPMicroorganisms · 2025
    Article
  4. Article
  5. Overexpression of the Wbl family regulator whiDWorld journal of microbiology & biotechnology · 2025
    Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yu-Si YanInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.ORCID 0009-0008-8111-4814
Li-Sha ZouInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.
He-Geng WeiZhejiang Yongtai Technology Co., LTD., Taizhou, Zhejiang, China.
Meng-Yao YangInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.
Yun-Qi YangInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.
Xiao-Fang LiInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.
Hai-Yang XiaInstitute of Biopharmaceuticals, Taizhou University, Taizhou, Zhejiang, China.ORCID 0000-0001-7068-4637
Taizhou University · CN

Funding

MOST | NSFC | NSFC-Zhejiang Joint Fund | | Natural Science Foundation of Zhejiang Province (ZJNSF) LY19C010002the Scientific Research Foundation of Taizhou 2001xg07the Scientific Research Foundation of Taizhou 21nya20the Scientific Research Foundation of Taizhou 22nya12the Scientific Research Foundation of Taizhou 23gya07
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EthersMacrolidesSpiro CompoundsStreptomycesBacterial ProteinsHistidine KinaseBacterial ProteinsEthersHistidine KinaseMacrolidesmoxidectinnanchangmycinSpiro Compoundsmilbemycinsnanchangmycinrewiring regulatory networkstrain engineeringStreptomyces bingchenggensistwo-component system

Identifiers

PMID38112424
PMCPMC10807435
OpenAlexW4389949160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.